220
Participants
Start Date
June 13, 2023
Primary Completion Date
June 10, 2027
Study Completion Date
February 12, 2028
AMG 305
Short-term intravenous (IV) infusion
RECRUITING
Chris OBrien Lifehouse, Camperdown
RECRUITING
Peter MacCallum Cancer Centre, Melbourne
RECRUITING
New York University Cancer Institute, New York
RECRUITING
Thomas Jefferson University, Philadelphia
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Universitario Madrid Sanchinarro, Madrid
RECRUITING
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse
RECRUITING
Sarah Cannon Research Institute, Nashville
RECRUITING
Universitaetsklinikum Essen, Essen
RECRUITING
Next Oncology, San Antonio
RECRUITING
City of Hope National Medical Center, Duarte
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Universitaetsklinikum Wuerzburg, Würzburg
RECRUITING
Hackensack University Medical Center, Hackensack
RECRUITING
Princess Margaret Cancer Centre, Toronto
RECRUITING
Universitaetsklinikum Dresden, Dresden
RECRUITING
National Cancer Center Hospital East, Kashiwa-shi
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Hospital Universitari Vall d Hebron, Barcelona
RECRUITING
Hospital Clinic i Provincial de Barcelona, Barcelona
RECRUITING
Beatson West of Scotland Cancer Centre, Glasgow
RECRUITING
Sarah Cannon Research Institute UK, London
RECRUITING
University College London Hospital, London
RECRUITING
Christie Hospital, Manchester
RECRUITING
Freeman Hospital, Newcastle
RECRUITING
Royal Marsden Hospital, Sutton
Lead Sponsor
Amgen
INDUSTRY